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Short telomeres trigger age-related pathologies and shorter lifespans in mice and humans. In
the past, we generated mouse embryonic (ES) cells with longer telomeres than normal
(hyper-long telomeres) in the absence of genetic manipulations, which contributed to all
mouse tissues. To address whether hyper-long telomeres have deleterious effects, we gen-
erated mice in which 100% of their cells are derived from hyper-long telomere ES cells. We
observe that these mice have longer telomeres and less DNA damage with aging. Hyper-long
telomere mice are lean and show low cholesterol and LDL levels, as well as improved glucose
and insulin tolerance. Hyper-long telomere mice also have less incidence of cancer and an
increased longevity. These findings demonstrate that longer telomeres than normal in a given
species are not deleterious but instead, show beneficial effects.
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Telomeres are nucleoprotein structures at the ends ofeukaryotic chromosomes1,2. They consist of tandemrepeats of the TTAGGG DNA sequence bound by six-
protein complex known as shelterin2,3. Telomeres are essential to
protect chromosome ends from DNA degradation and DNA
repair activities and they play an important role in chromosome
stability4,5. Telomeres shorten with every cell division owing to
the so-called “end replication problem”6–8. Telomerase is a
ribonucleoprotein DNA polymerase that can elongate telomeres
by de novo addition of TTAGGG repeats onto the chromosome
ends9, thus compensating for telomere attrition. Telomerase
consists of a reverse transcriptase catalytic subunit (known as
TERT) and an associated RNA component (Terc), which is used
as a template for the synthesis of TTAGGG repeats. In the adult
organism, telomerase activity is restricted to stem cell compart-
ments although this is not sufficient to prevent progressive telo-
mere shortening with aging10,11. When telomeres reach a
critically short length, they induce a persistent DNA damage
response (DDR) which induces other cellular events, such as
cellular senescence and/or apoptosis, as well as impairs the ability
of stem cells to regenerate tissues5,12–14. Telomere shortening is
considered one of the hallmarks of aging as short telomeres are
sufficient to cause organismal aging and decreased lifespan15–18
Telomere length is determined genetically and both average tel-
omere length and the rate of telomere shortening varies between
species19,20. In this regard, humans are born with shorter telo-
meres than mice, but mice telomeres shorten 100-times faster
than humans21–23.
In mice, we and others have previously demonstrated that
telomerase is activated at the blastocyst stage where telomeres are
elongated in the inner cell mass (ICM), in this manner setting the
normal telomere length of a given species24–26. Interestingly, we
also found that in vitro expansion of embryonic stem (ES) cells
derived from the ICM allows for additional telomere elongation
beyond the normal telomere length of the species, generating the
so-called hyper-long telomere ES cells25,26. This telomere elon-
gation is associated with epigenetic changes during the plur-
ipotency stage which allow for a more “open” telomeric
chromatin structure and for telomerase-mediated telomere
extension in the absence of conspicuous gene expression changes
(ref. 11; ref. 25,26). Recently, we demonstrated that these ES cells
with hyper-long telomeres can be aggregated into morulae to
obtain chimeric mice which are also made of cells with longer
telomeres than those of the natural species26. Thus, ES cells with
hyper-long telomeres are able to contribute to all adult organs,
and do not affect their normal architecture and function26.
However, further studies are necessary to address the long-term
effects of increasing the natural telomere length of a species.
To this end, here we generate chimeric mice with a 100%
contribution from ES cells with hyper-long telomeres, that have
longer telomeres than normal in the whole organism (referred
here as “hyper-long telomere mice”). We observe that hyper-long
telomere mice are significantly leaner than control mice. We
further show that this reduction in body size is concomitant with
a lower accumulation of white adipose tissue (WAT) in the
organism. Interestingly, mice with hyper-long telomeres also
show an improved glucose metabolism compared to control mice,
as indicated by an improved glucose and insulin tolerance
throughout life. In agreement with less metabolic aging, these
mice show longer telomeres in the liver and the white adipose
tissue even at older ages. Importantly, mice with hyper-long tel-
omeres show an increased longevity and develop less tumors
associated with aging. Together, these findings demonstrate that
longer telomeres than normal show beneficial effects in mice,
delaying metabolic aging and cancer, and resulting in longer
lifespans.
Results
Mice with longer telomeres than those of the natural species.
We previously showed that it is possible to generate mouse ES
cells with hyper-long telomeres in the absence of any genetic
manipulations, and that these ES cells can be used to generate
mouse chimeras, which carry cells with longer telomeres than
those of the natural species26. In order to address the impact of
excessively long telomeres in a given species, here, we have
generated a cohort of chimeric mice with a 100% contribution
from ES cells with hyper-long telomeres ES cells. To this end,
~100 morulae at the eight-cell state were microinjected with 6–10
GFP-positive female ES cells with hyper-long telomeres at passage
16 by laser-assisted perforation of the “zona pellucida” obtaining
chimeric mice which were 100% contributed by the GFP-positive
ES cells (Fig. 1a). In particular, adult mice (1.5–2 years of age)
showed 100% of their cells positive for eGFP as determined by
immunohistochemistry (IHC) with anti GFP antibodies in dif-
ferent mouse tissues (Fig. 1b). The fact that, even at old age,
chimeric mice show 100% of the cells that are GFP-positive, and
therefore are derived from ES cells with hyper-long telomeres,
indicates that these cells with hyper-long telomeres are not
negatively selected during aging. Further supporting that cells
with hyper-long telomeres are not deleterious, all mouse tissues
showed a normal histology even at older ages (Fig. 1b). Strikingly,
hyper-long telomere mice were significantly leaner than control
mice from the same genetic background (Fig. 1c). To further
study this unexpected phenotype, we carried out a longitudinal
follow-up of mouse weight throughout their entire lifespan and
found that hyper-long telomere mice showed a significant
reduction in body weight which started from 40 weeks of age
onwards (Fig. 1d).
Thus, here we generated viable mice that are 100% contributed
by ES cells with hyper-long telomeres. We did not find any overt
phenotypes in these mice other than they are leaner compared to
normal mice.
Less fat accumulation in hyper-long telomere mice. In order to
investigate the leaner phenotype of hyper-long telomere mice, we
performed densitometry assays at 75 and 100 weeks of age in both
hyper-long telomere mice and normal telomere length controls
from the same genetic background. We found that hyper-long
telomere mice showed significantly lower fat content than age-
matched control mice at two different ages (75 and 100 weeks-
old) (Fig. 2a). In contrast, no differences were observed in either
bone mineral density (BMD) (Fig. 2b) or in total lean mass
between hyper-long telomere mice and the normal telomere
length controls (Fig. 2c). In agreement with lower fat accumula-
tion, hyper-long telomere mice also showed a significantly
reduced skin subcutaneous fat layer compared to age-matched
control mice (100 weeks of age) (Fig. 2d, e). These results indicate
that the reduced body size of hyper-long telomere mice is due to a
lower accumulation of fat.
Improved metabolic parameters in hyper-long telomere mice.
As mice with hyper-long telomeres showed reduced fat accu-
mulation, we next set to determine different metabolic para-
meters. First, we measured the levels of albumin, creatinine,
bilirubin, urea, alanine aminotransferase (ALT), cholesterol, the
low-density lipoprotein (LDL), and the high-density lipoprotein
(HDL) in blood serum from both hyper-long telomere mice and
age-matched controls at 50, 75, and 100 weeks of age. We found
no significant differences in the levels of creatinine, bilirubin,
albumin, urea and, HDL at any of the time points between hyper-
long telomere mice and control mice (Fig. 3a–e). Interestingly,
hyper-long telomere mice showed significantly lower levels of the
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“bad cholesterol”, LDL, compared to control mice at the three
time points studied (Fig. 3f). Hyper-long telomere mice also
showed significantly lower levels of cholesterol and of the hepatic
damage marker ALT compared with control mice (Fig. 3g, h).
Thus, we found lower cholesterol levels, including LDL levels, and
decreased liver damage in hyper-long telomere mice compared to
control mice.
To further asses the metabolic effects of hyper-long telomeres,
we next studied glucose metabolism by performing a glucose
tolerance test (GTT). To this end, glucose was injected
intraperitoneally in age-matched hyper-long telomere mice and
normal telomere mice at 50, 75, and 100 weeks of age previously
fasted for 16 h. At all timepoints, hyper-long telomere mice
showed an increased glucose sensitivity (Fig. 3i–k). We obtained
similar results when we performed an insulin tolerance test (ITT).
In this case, hyper-long telomere mice showed a better insulin
tolerance at both 75 and 100 weeks of age compared to the
normal telomere length controls (Fig. 3l–n).
In summary, these results indicate that hyper-long telomere
mice have an improved metabolic fitness compared to normal
telomere length mice. In particular, they show lower levels of
LDL, cholesterol, and ALT in blood, as well as are more sensitive
to glucose and insulin even at old age (100-weeks old), suggesting
less metabolic aging compared to age-matched control mice.
Hyper-long telomere mice live longer and have less sponta-
neous tumour incidence. Critically short telomeres in humans
and mice can lead to premature aging and shorter lifespans by
limiting the ability of stem cells to regenerate tissues11,12,27. In
turn, we previously showed that longer telomeres owing to telo-
merase over-expression in adult mice can increase mouse
longevity17,28. Thus, here we set to address whether longer telo-
meres than normal in the adult organism, in the absence of tel-
omerase over-expression, were sufficient to increase longevity.
Strikingly, we found that hyper-long telomere mice showed a
significant increase of 12.75% in median longevity as well as an
increase in maximum longevity of 8.40% compared to normal
telomere length controls (Fig. 4a). These findings indicate that
long telomeres per se, even in the absence of telomerase over-
expression, are sufficient to increase mouse longevity.
The fact that hyper-long telomere mice had an increased
longevity also suggested that they were unlikely to have any
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Fig. 1 Hyper-long telomere mice are leaner than normal mice. a Scheme showing generation of mice with hyper-long telomeres. eGFP ES cells are cultured
in 2i medium until passage 16 and they are microinjected into morulae to obtain 100% contributing chimaeras. b Representative images showing 100%
eGFP ES cell contribution in different organs and tissues. c, d Longitudinal follow up of weight in the indicated cohorts. Hyper-long telomere mice show a
significant reduction in body weight from 40 weeks onwards (c) and this body size reduction is maintained until the last timepoint measured (c, d). Error
bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. Source data are
provided as a Source Data file
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particular importance because previous works have correlated
presence of long telomeres in humans with increased cancer
incidence29–33. To address this, we studied the spontaneous
tumor incidence of hyper-long telomere mice and control mice.
We found that hyper-long telomere mice showed a reduction of
almost 50% in the number of mice that developed tumors
compared to the normal telomere length control mice, although
this difference did not reach significance (Fig. 4b). Of notice, the
cause of death of tumor free mice was associated to general body
degeneration associated to the aging process, as well as uterine
infection in some female mice.
These findings clearly demonstrate that long telomeres per se
do not lead to increased cancer, at least in mice. Instead, longer
telomeres are clearly correlated with an increased mouse
longevity.
Hyper-long telomere mice have normal cognitive capabilities.
Next, we wondered whether having longer telomeres than
normal could affect cognitive capabilities in these mice. To
address this, we performed different cognitive tests at 50, 75,
and 100 weeks of age. To evaluate neuromuscular endurance,
we performed a rotarod test, which measures the time that mice
are able to stay on a rotating platform with accelerated move-
ment without falling (Supplementary Fig. 1a). We observed no
differences between the hyper-long telomere mice and the
control mice at the different time points (Supplementary
Fig. 1b). In order to study mouse coordination, we performed a
tightrope test, which evaluates the capability of the mice to stay
on a rope without falling during at least 1 min (Supplementary
Fig. 1c). Again, we did not see any significance difference in
performance between the hyper-long telomere mice and the
controls (Supplementary Fig. 1d). Finally, to measure the sen-
sory perception of mice we used a buried food test, in which we
measured the ability of mice to find a buried food pellet after 16
h fasting (Supplementary Fig. 1e). Again, we found no differ-
ences between hyper-long telomere mice and controls (Sup-
plementary Fig. 1f).
Together, these results suggest that hyper-long telomere mice
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Fig. 2 Reduced body size in hyper-long telomere mice is due to lower fat accumulation. a–c Densitometry analysis of hyper-long telomere mice and
normal mice at two different ages. a Quantification of percentage of total fat. b Quantification of bone density. c Quantification of total lean mass.
d, e Quantification of the skin subcutaneous fat layer in 100 weeks-old hyper-long mice and age-matched controls (d), and representative image showing
skin subcutaneous fat layer thickness. Measurements were done by ImageJ software and calculated by the mean value of 30–40 different measurements
all over the skin subcutaneous fat layer. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each
case. *p < 0.05. ***p < 0.001. Source data are provided as a Source Data file
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Fig. 3 Hyper-long telomere mice show less metabolic aging. a–h Pentra quantification of different serum metabolites at 50, 75, and 100 weeks-old.
Metabolites were measured in serum obtained from blood extracts using ABX Pentra, a quantification of creatinine levels, b quantification of total bilirubin
levels, c quantification of albumin levels, d quantification of urea levels, e quantification of HDL (high density lipoprotein) levels, f quantification of LDL (low
density lipoprotein) levels, g quantification of ALT (alanine aminotransferase) levels and h quantification of cholesterol levels. i–k Glucose tolerance test
(GTT). GTT was performed in hyper-long telomere mice and age-matched controls at 50 (i), 75 (j) and 100 (k) weeks of age by intraperitoneal glucose
injection after 16 h fasting. l–n Insulin tolerance test (ITT). ITT was performed in hyper-long telomere mice and age-matched controls at 50 (l), 75 (m) and
100 (n) weeks of age by intraperitoneal insulin injection. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is
indicated in each case. *p < 0.05. **p < 0.01. ***p < 0.001. Source data are provided as a Source Data file
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Hyper-long telomere mice retain longer telomeres at old ages.
In order to determine whether hyper-long telomere mice retained
longer telomeres even at old age, we measured telomere length in
different tissues at 100 weeks of age. Telomere length was
determined in intestine and skin, as examples of proliferative
tissues, and in brain as a non-proliferative tissue. We found that
in all cases, 100-weeks old hyper-long telomere mice showed
longer telomeres on average, than the normal age-matched con-
trols (Fig. 5a–f). In agreement with longer telomeres, hyper-long
telomere mice also showed a significantly lower accumulation of
short telomeres at old age compared with the age-matched con-
trol mice (Fig. 5a–f).
Importantly, as one of the main phenotypes in the hyper-long
telomere mice is an improved metabolic profile, we measured
telomere length and percentage of short telomeres in metaboli-
cally relevant tissues, such as the liver, white adipose tissue
(WAT), and brown adipose tissue (BAT) at 100–110 weeks old.
Interestingly, we found a very pronounced increase in telomere
length in the hyper-long telomere mice in all three metabolic
tissues compared to control mice from the same background
(Fig. 6a–f). Accordingly, we observed a significant decrease in the
percentage of short telomeres in the hyper-long telomere mice
compared to controls in all three tissues (Fig. 6a–f).
To rule out that longer telomeres in the hyper-long telomere
mice where the result of an altered telomerase expression in the
adult organism we determined mRNA levels of the two essential
telomerase components Tert and Terc in hyper-long telomeres
and normal telomere mice at 100–110 weeks of age in the liver
and the WAT. As expected, we found that Tert was not expressed
in these tissues in agreement with previous reports showing that
Tert expression is undetectable in the majority of adult mouse
tissues after birth10,17. Furthermore, we did not see any significant
differences in the mRNA expression of Terc between the hyper-
long telomere mice and the normal controls in the liver and the
WAT (Fig. 7a–d).
Altogether, these results demonstrate that hyper-long telomere
mice retain longer telomeres with aging, including metabolic
tissues such liver, white adipose tissue and brown adipose tissue,
in the absence of Tert overexpression.
Hyper-long telomere mice show less senescence and DNA
damage. Next, we addressed whether longer telomeres than
normal could be promoting or protecting from age-associated
DNA damage. To this end, we performed a telomere Q-FISH to
identify telomeres followed by an immunofluorescence against
the DNA damage marker 53BP1 in liver of 100 weeks hyper-long
telomere chimaeras and controls. To this end, we quantified the
number of cells presenting ≥2 53BP1 foci (Fig. 8a, c). Interest-
ingly, hyper-long telomere mice show an 8-fold decrease in
53BP1-positive cells compared to controls (Fig. 8a). Importantly,
the percentage of cells presenting ≥1 telomere induced foci (TIF)
also show a very significant 6-fold decrease in hyper-long telo-
mere mice compared to controls (Fig. 8b, c).To further investigate
whether longer telomeres than normal protect from DNA
damage, we quantified the percentage of cells positive for the
senescence marker, p21, in the liver of age matched (100 weeks of
age) normal length and hyper-long telomere mice. Interestingly,
we found a significant 9-fold decrease in the number of p21
positive cells in hyper-long mice compared with age-matched
controls (Fig. 8d, e).
Together, these results indicate that longer telomeres than
normal in hyper-long telomere mice significantly reduce the
global DNA damage and the telomeric DNA damage associated
with aging in mice.
Enhanced mitochondrial function in hyper-long telomere
mice. Since previous works have reported a relation between
telomere and mitochondrial homeostasis34,35, here we next
addressed whether hyper-long telomeres could be also affecting
mitochondrial function. To this end, we first performed a qPCR-
based assay in order to determine the relative mitochondrial
DNA (mtDNA) copy number in WAT of 100–110-week old mice
using three different mitochondrial genes (Cox1, Cytb, and Nd1).
Interestingly, we find that relative mtDNA copy number in WAT
of hyper-long telomere mice is double those of control mice from
the same background according to the three genes mitochondrial
analyzed (Fig. 9a–c).
Next, we also measured mRNA expression levels of the
different oxidative phosphorylation genes (OXPHOS) Cyto-
chrome C, ATP synthase, Cytochrome C subunit 6 and
Cytochrome C subunit 5a as well as mitochondrial regulators
PGC-1α and PGC-1β and critical targets such as ERRα and
PPARα. Concomitant with our previous result, we found a
significant upregulation in all these genes in hyper-long telomere
mice compared to the normal length age-matched controls
(Fig. 9d–k).
Taken together, these data suggest that mice with hyper-long
telomeres have an improved mitochondrial function, which could
be also contributing to their delayed aging phenotype and
improved metabolic function.
Normal expression of RAP1 in mice with hyper-long telomeres.
We previously showed that mice deficient for the RAP1, a com-
ponent of the shelterin telomere protective complex, showed an
obese phenotype as well as signs of metabolic syndrome including
abnormal fat accumulation, glucose intolerance and fatty liver36. As
we found here that hyper-long telomere mice are protected from
age-associated metabolic syndrome, including fat accumulation,
high cholesterol levels, liver damage and glucose intolerance, we set








































































Fig. 4 Hyper-long telomere mice live longer and have less spontaneous
cancer. a Survival proportions of 100% hyper-long chimeric mice compared
to control mice from the same background. Hyper-long telomere mice show
a 12.75% increase in median lifespan and an 8.4% increase in maximum
lifespan. b Quantification of spontaneous tumor incidence in hyper-long
telomere mice and controls. Hyper-long telomere mice show a decrease in
almost 20% in tumor incidence compared to control mice from the same
background. Error bars represent standard error. Mantel–Cox test was used
for statistical analysis in survival curves and Chi-square test for
spontaneous tumor incidence. The number of mice is indicated in each
case. *p < 0.05. **p < 0.01. ***p < 0.001. Source data are provided as a
Source Data file
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the RAP1 protein. To this end, we first determined RAP1 protein
levels by Western blot in the white adipose tissue (WAT). We
found that RAP1 protein levels were similar in age-matched
100–110 weeks-old hyper-long telomere and normal telomere
length controls (Supplementary Fig. 2a, b). Similarly, we detected
similar RAP1 protein levels in the liver of hyper-long and normal
telomere length mice as determined by immunofluorescence (IF)
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Fig. 5 Hyper-long telomere mice show longer telomeres throughout their lifespan in both proliferative and non-proliferative tissues. a–f Mean telomere
fluorescence and percentage of short telomeres in back skin (a, b), intestine (c, d), brain (e, f) in 100 weeks-old hyper-long telomere mice and age-
matched controls. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p <
0.01. ***p < 0.001. Source data are provided as a Source Data file
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Fig. 6 Hyper-long telomere mice show longer telomeres throughout their lifespan in metabolic-related tissues. a–f Mean telomere fluorescence and
percentage of short telomeres in liver (a, b), white adipose tissue (c, d) and brown adipose tissue (e, f), in 100 weeks-old hyper-long telomere mice and
age-matched controls. Error bars represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05.
**p < 0,01. ***p < 0,001. Source data are provided as a Source Data file
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12664-x
8 NATURE COMMUNICATIONS |         (2019) 10:4723 | https://doi.org/10.1038/s41467-019-12664-x | www.nature.com/naturecommunications
findings suggest that protection from metabolic syndrome in mice
with hyper-long telomeres does not seem to be related to altered
levels of the RAP1 protein.
Next, we addressed whether hyper-long telomeres resulted in
altered levels of the rest of the components of shelterin. To this
end, we determined the mRNA expression levels of the different
shelterin components in the liver and WAT of 100–110-week old
mice. Again, although we observed a tendency to lower
expression levels of the different shelterin components in
hyper-long telomere mice compared to the controls both in the
liver, this difference did not reach statistical significance
(Supplementary Fig. 2e–k), similar findings were observed and
in the white adipose tissue (Supplementary Fig. 2l–r). Thus,
hyper-long telomeres in mice do not alter the mRNA expression
of Rap1 or the different shelterin components.
Discussion
It has been previously described that telomere elongation is only
possible in certain adult stem cell compartment in which telo-
merase is partially active in both human and mouse and
even in these cells telomerase expression is not enough to
maintain telomere homeostasis throughout the lifespan of
organisms10,17,21,23,37. Indeed, although mice are born with
longer telomeres than humans the rate of telomere shortening in
mice is up to 100-folder higher21,23 and both humans and mice
show progressive telomere shortening with aging17,23,38. In turn,
telomere shortening with aging can trigger a number of secondary
pro-aging phenomena such as increased DNA damage and
genomic instability, cellular senescence and/or apoptosis,
impaired ability of stem cells to regenerate tissues etc., and
therefore it is considered one of the primary hallmarks of orga-
nismal aging (ref. 18). In turn, telomere maintenance in the adult
organisms by using different telomerase over-expression
approaches, including gene therapy strategies, have been shown
to delay aging and age-associated pathologies, as well as to
increase lifespan in mice17,28,39–42.
However, telomerase has been found re-activated in the
majority of human cancers43 and this has generated a certain
concern on potential negative long-term effects of telomerase
reactivation in promoting tumorigenesis. In this regard, there is
mounting evidence that telomerase re-activation in the adult
organism by using non-integrative gene adeno associated vectors
(AAV) does not lead to increased cancer, even in the context of
activated oncogenes, in mice44–47. In humans, presence of longer
telomeres than normal has been also associated to increased
incidence of certain cancers such as lung cancer in large popu-
lation studies29–33. In addition, germinal mutations in the Pot1
shelterin gene, which lead to longer telomeres than normal, have
been also associated to various types of familial cancer, such as
melanoma, Li-fraumeni like, and glioma48–54. Although in the
latter case scenario, Pot1 mutations not only lead to longer tel-
omeres, but also increased telomere aberrations, which could be
responsible of the increased cancer susceptibility48,50–54. Thus, it
is of relevance to address whether long telomeres per se, in the
absence of telomerase activation or other telomere alterations,
could be promoting tumorigenesis or not.
In the past, we demonstrated that it is possible to elongate
telomeres during in vitro expansion of ES cells beyond the normal
length of the species in the absence of any genetic manipula-
tions25 and to use this ES cells with hyper-long telomeres to
generate healthy chimeric mice derived from these ES cells with
hyper-long telomeres26. Here, in order to address any potential
long-term deleterious effects of longer telomeres than normal in
the context of an organism, we generated chimeric mice that are
100% contributed from ES cells with hyper-long telomeres
(hyper-long telomere mice), and followed these mice during their
entire lifespan.
We found that these mice derived from ES cells with hyper-
long telomeres, retained longer telomeres than normal at older
ages and showed no pathological abnormalities. Accordingly, we
also found a significantly decreased number of cells presenting
global DNA damage, as well as telomere-induced DNA damage
with aging in the hyper-long telomere mice compared to the
normal telomere controls. Also, the levels of the p21 senescence
marker were decreased in the hyper-long telomere mice.
Interestingly, hyper-long telomere mice showed a reduced
body weight than normal from week 40 onwards. We further
found that this reduced size is due to a lower accumulation of fat
in the absence of changes in the lean mass. Furthermore, hyper-
long telomere mice show signs of a “younger” metabolic phe-
notype, as indicated significantly reduced levels of LDL, ALT, and
cholesterol in serum throughout their lifespan. Moreover, they
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Fig. 7 Hyper-long telomere mice does not present altered telomerase expression levels. a–d Tert and Terc mRNA expression levels as measured by Q-PCR
in liver (a, b) and in white adipose tissue (c, d) in age-matched (100 weeks old) hyper-long telomere mice and control mice. Error bars represent standard
error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0,01. ***p < 0,001. Source data are provided as a
Source Data file
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at old age, thus supporting a “younger” metabolic age in the case
of hyper-long telomere mice compared to the normal telomere
length controls.
Previous reports have shown decreased mitochondrial function
associated to telomere dysfunction34,35. In agreement with these
previous findings, our current data suggest that mice with hyper-
long telomeres have an improved mitochondrial function. In
particular, we found that hyper-long telomere mice show
increased expression of Pgc1-α/β as well as of their target genes
Errα and Pparα. Moreover, hyper-long telomere mice also show
increased mitochondrial DNA copy number and increased
expression levels of the OXPHOS mitochondrial genes Cyto-
chrome C, ATP synthase, Cytochrome C subunit 6 and Cyto-
chrome C subunit 5a compared to normal telomere controls.
Together, these findings suggest that mitochondrial activity is
enhanced in mice with hyper-long telomeres, and this could
contribute to their improved metabolic performance.
Importantly, we did not see increased incidence of spontaneous
tumors in the hyper-long telomere mice, which instead, showed a
clear tendency to have reduced spontaneous tumors, compared to
the normal telomere length control, thus indicating that long
telomere per se do not increase tumorigenesis, instead, seem to be
decreasing cancer risk in agreement with a younger state. Also in
agreement with this, we found that hyper-long mice lived longer
than controls with a 12.75% increase in median survival and 8.4%
in maximum survival. It could be argued that the 100% chimeric
mice used in this study maybe derived from a donor trophoblast
whose gender could impact in the survival of these mice. How-
ever, it is known55,56 that trophoblast cells contribute entirely to
form the placenta and the amniotic sac and are not likely to affect
adult mice.
Overall, here we present a mouse model with delayed aging in
the absence of genetic manipulations. This mouse model features
anti-aging phenotypes that are also present in several genetically
a c
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Fig. 8 Hyper-long telomere mice show less DNA damage and less senescence. a, b Quantification of DNA damage in age-matched (100 weeks old) hyper-
long telomere mice and control mice. Quantification of total damage as indicated by percentage of cells with ≥2 53BP1 foci as determined by
immunofluorescence (a) and quantification of cells showing telomere-induced DNA damage as shown by percentage of cells with ≥1 TIF (telomere
induced foci) as determined by telomere FISH followed by immunofluorescence with 53BP1 antibody (b). c Representative images of TIFs (yellow arrow).
d Quantification of the percentage of p21 positive cells in liver of age matched (100 weeks old) hyper-long telomere mice and control mice.
e Representative images of p21 (red arrows) positive cells. Error bars represent standard error. t-test was used for statistical analysis. The number of mice
is indicated in each case. **p < 0.01. Source data are provided as a Source Data file
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Fig. 9 Improved mitochondrial function in mice with hyper-long telomeres. a–c. Relative mtDNA content was calculated by the comparative Ct method of
the mitochondrial genes Cox1 (a), Cytb1 (b) and Nd1 (c) compared to the nuclear gene H19 in WAT of 100–110 weeks old hyper-long telomere mice and
age-matched controls. d–k. mRNA levels from WAT of the OXPHOS genes Cytochrome C (d), ATP synthase (e), Cytochrome C subunit 6 (f) and
Cytochrome C subunit 5a (g) as well as mitochondrial regulators PGC-1a (h) and PGC-1b (i) and critical targets, such as ERRa (j) and PPARa (k). Error bars
represent standard error. t-test was used for statistical analysis. The number of mice is indicated in each case. *p < 0.05. **p < 0.01. Source data are
provided as a Source Data file
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modified mouse models with delayed aging previously described.
In particular, our model shows reduced body size, enhanced
insulin sensitivity and even reduced incidence of fatal neoplastic
disease, similar to the growth hormone (GH) mutant dwarf
mice57–60, although there are notable differences such as lower
body fat, which dwarf mice tend to accumulate60. In this regard,
mice with hyper-long telomeres are more similar to insulin-like
growth factor (IGF) mutant mice, which also feature decreased
body fat accumulation60.
In summary, we demonstrate here that it is possible to generate
mice that have telomeres which are much longer than those of the
natural species by increasing the passage number of embryonic
stem cells and in the absence of genetic modifications. These mice
show a younger phenotype as indicated by improved mitochon-
drial function, improved metabolic parameters, decreased cancer,
and increased longevity. These results also suggest that there is
not a negative selection for individuals with longer telomeres than
normal in species, and therefore, one can envision that natural
selection processes which favor individuals with longer telomeres
within a given species, could potentially increase species long-
evity. Finally, these findings also suggest the intriguing possibility
that a potential mechanism for rending individuals with longer
telomeres could be regulation of the duration of pluripotency
stages during embryonic development when telomeres are
elongated.
Methods
Chimaera generation. ES cells were harvested from R1-eGFP 129S1 mouse
embryos and cultured until passage 16 in 2i medium to allow telomere elonga-
tion26. Chimeric mice were generated at the CNIO Transgenic Mice Unit by
microinjection of R1-eGFP ES cells into Hsd:ICR (C57Bl6 background). Embryos
were harvested from super ovulated donor females at E2.5 days of gestation.
Approximately 100 morulae at the eight-cell state were microinjected with 6–10
EGFP-expressing ES cells by laser-assisted perforation of the “zona pellucida”.
After microinjection, embryos were incubated overnight in a drop of KSOM
medium in a CO2 incubator at 37 °C under oil.
As a control for this study R1-eGFP 129S1 female mice were used in all the
experiments.
Mice. All mice were maintained at the Spanish National Cancer Centre under
specific pathogen-free conditions in accordance with the recommendations of the
Federation of European Laboratory Animal Science Associations (FELASA). All
animal experiments were approved by our Institutional Animal Care and Use
Committee (IACUC) and by the Ethical Committee for animal experimentation
(CEIyBA) (PROEX 133/15). We followed the Reporting in Vivo Experiments
(ARRIVE) guidelines developed by the National Centre for the Replacement,
Refinement & Reduction of Animals in Research (NC3Rs).
Immunohistochemistry analyses in tissue sections. Tissues were fixed in 10%
buffered formalin, embedded in paraffin wax and sectioned at 5 mm. For histo-
logical examination sections were stained with hematoxylin and eosin, according to
standard procedures. GFP (Cell Signaling, cat. number 2956) and p21 (291 H/B5,
homemade) antibody was used for immunohistochemistry in tissue sections, both
diluted 1:500. Nuclei were counterstained with Harrys’s hematoxylin. Pictures were
taken using Olympus AX70 microscope.
Densitometry assay. Body composition (percentage of total fat, bone densito-
metry and total lean) was measured using dual-energy X-ray absorptiometry
(DEXA) PIXImus, Mouse Densitometer (GE Lunar co, Madison, WI, USA) using
software version 1.46. Mice were anesthetized via gaseous anesthetic (isoflurane)
with a continuous flow of 1% to 3% isoflurane/oxygen mixture (2 L/min), for ~10
min during recording. Quality control was performed using a calibrated phantom
before imaging.
Subcutaneous fat thickness. Thickness of the subcutaneous fat layer was mea-
sured as previously described61. Briefly, a total of 30 measurements were performed
on 2 back sections of the skin for each mouse around 100 weeks old. Measurements
were made using Panoramic Viewer software and ImageJ software.
Metabolic measurements. Serum levels of albumin, creatinine, bilirubin, urea,
alanine aminotransferase (ALT), cholesterol, low density lipoprotein (LDL) and
high density lipoprotein (HDL) were determined using ABX Pentra (Horiba
Medical). To perform GTT and ITT, mice were i.p. injected with 2 g of glucose/kg
of body weight and 0.75 U insulin/kg of body weight (Eli Lilly; Humalog Insulin),
respectively. In the case of GTT mice were previously fasted for 16 h. For ITT mice
were not fasted and basal levels of glucose were between 80–100 mg/dL.
Cognitive tests. To measure coordination mice were tested in a Rotarod apparatus
(model LE 8200). For balance mice were tested by the tightrope test, as previously
described17,28. To check smell capacities mice were tested by the buried food test62.
Briefly, mice were fasted for 16 h and they were placed in a cage with a buried pellet
of food. Analysis was made by calculating the percentage of success and the total
time spent to find the pellet.
Telomere length analyses. Quantitative telomere fluorescence in situ hybridiza-
tion (Q-FISH) was performed directly on paraffin-embedded lung sections as
previously described12 and analyzed by Definiens software. The incidence of short
telomeres was calculated as the percentage of telomeres below the 25th percentile of
telomere fluorescence in control samples.
Real-time qPCR. Total RNA from cells was extracted with the RNeasy kit
(QIAGEN) and reverse transcribed was using the iSCRIPT cDNA synthesis kit
(BIO-RAD) according to manufacturer’s protocols. Quantitative real-time PCR
was performed with the QuantStudio 6 Flex (Applied Biosystems, Life Technolo-
gies) using Go-Taq qPCR master mix (Promega) according to the manufacturer’s

























Cytochrome c oxidase subunit 6-F 5′-GTAACGCTACTCCGGGACAA-3′
Cytochrome c oxidase subunit 6-R 5′-TCCAGGTAGTTCTGCCAACA-3′
Cytochrome c oxidase subunit 5a-F 5′-CTCGTCAGCCTCAGCCAGT-3′









Immunofluorescence analyses on tissue sections. For immunofluorescence
analyses, tissue sections were fixed in 10% buffered formalin (Sigma) and
embedded in paraffin. After desparaffination and citrate antigen retrieval, sections
were permeabilized with 0.5% Triton in PBS and blocked with 1% BSA and 10%
Australian FBS (GENYCELL) in PBS. The antibodies were applied overnight in
antibody diluents with background reducing agents (Invitrogen). Primary anti-
bodies: anti-Rap1 (BL735, Bethyl, cat. number A300-306A), anti-53BP1 (Novus
Biologicals, cat. Number NB100-304). Immunofluorescence images were obtained
using a confocal ultraspectral microscope (Leica TCS-SP5). Quantifications were
performed with Definiens software. A double immunofluorescence using anti-
bodies against 53BP1 to mark DNA damage foci and TRF1 to mark telomeres was
performed in tissue sections to assay for telomeric DNA damage specifically located
at telomeres. All antibodies were diluted 1:500 for the experiments.
Western-blot analyses. Total protein extracts were obtained using RIPA
extraction buffer and protein concentration was determined using the Bio-Rad DC
Protein Assay (Bio-Rad). Up to 20 micrograms of protein per extract were sepa-
rated in SDS–polyacrylamide gels by electrophoresis. After protein transfer onto
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nitrocellulose membrane (Whatman), the membranes were incubated with the
indicated antibodies. Antibody binding was detected after incubation with a sec-
ondary antibody coupled to horseradish peroxidase using chemiluminescence with
ECL detection KIT (GE Healthcare). Primary antibodies: anti-TRF1 (BED5, Cell
Signaling), anti-RAP1 (Bethyl), anti-SMC-1 (Bethyl). Quantifications: Protein-
band intensities were measured with ImageJ software and normalized against the
loading control.
Mitochondrial copy number. Relative mtDNA content were obtained by the
comparative Ct method63,64. Briefly, we measured by qPCR the mtDNA genes
Cox1, Cytb and Nd1 and the nuclear DNA (nucDNA) gene H19. Then we sub-
tracted the mtDNA averaged Ct values from the nucDNA averaged Ct values
obtaining the ΔCt. We finally calculated the relative mitochondrial DNA content
by raising 2 to the power of ΔCt and then multiplying by 2. Expressed as equations:
ΔCt ¼ nucDNACtmtDNACt:
Relativemitochondrial DNA content ¼ 2 ´ 2ΔCt:









Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request. The source data underlying Figs. 1–9 are provided as a
Source Data file.
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